The Largest Vaccine Partnering Event in China: VacChina 2013

VacChina 2013

Date: March 13^th- 14^th, 2013

Venue:Intercontinental Pudong, Shanghai, China

 

http://vac2013./index.asp

 

This is the largest annual vaccine event gathering in China and covers the entire value chain of the vaccine industry. VacChina 2013 will assess the latest industrial trends, R&D strategies, partnership models and manufacturing technology advancements in Asian especially in Chinese vaccine market. Meanwhile, it will highlight companies how to entry into the important markets in Asia as well. Our aim is to promote global and regional partnering in business development, R&D and manufacturing, assist local vaccine companies to find a feasible way to open the global market through strategic brainstorm.

VacChina International 2013:

This is the largest annual vaccine event gathering in China and covers the entire value chain of the vaccine industry. It will assess the latest industrial trends, R&D strategies, partnership models and manufacturing technology advancements in Asian especially in Chinese vaccine market. Meanwhile, it will highlight companies how to entry into the important markets in Asia as well. Our aim is to promote global and regional partnering in business development, R&D and manufacturing，assist local vaccine companies to find a feasible way to open the global market through strategic brainstorm.

Key Features of Asia Pharma R&D Leaders 2013

Conference –300+ executive level attendees from 10 countries and regions working within R&D strategy, Clinical, Partnering, Manufacturing, Quality Assurance etc
Technology – from Biotech, cell culture, virus removal, purification, single-use Tech etc on showcase
Seminars – 40+ eminent speakers with 60 seminars featuring technical and strategic topics
Posters - 100 posters from leading research institutes on showcase
Top Life Science VC/PE – 30+ Asian and global life science VC/PE looking for investment opportunities in China
One on One Partnering Meetings –60 prescheduled one to one business meetings

Who should attend?

Chief Executives, Vice President, Scientists, Directors, General Managers and:

• Head of Vaccine R&D
• Head of Clinical R&D
• Medical Directors
• Head of Clinical Development
• Head of Preclinical Developm- ent
• Head of Regulatory Affairs
• Head of Biostatistics
• Head of Safety Assessment
• Head of Clinical Operations
• Head of Pharmacovigilance
• Head of Clinical Risk Management
• Head of Exploratory Develop -ment
• Head of Biometric
• Head of Study Feasibility and Patient Enrolment
• Head of clinical data manage- ment
• Head of Medical Affairs
• Head of Project Management
• Head of Global Research
• Head of Drug Discovery
• Chief Scientific Officer
• Principal Scientist
• Principle Clinical Investigator
• Chief Technology Officer
• Head of Stemcell Research
• Head of Chemistry
• Head of Manufacturing Attendee From
  • Vaccine Manufacturer
  • Biotechs
  • CROs
  • Academics and Research Institutes
  • Technology Providers
  • Venture Capitalists
  • Research equipment providers
  • Consulting

For further information, please contact us:

Sky Zhong Team Leader of Life Science Dept.
Call: +86 21 5242 8136
Fax: +86 21 5236 0029
E-Mail: sky.zhong@  

Daniel Chen Project Manager
Call: +86 21 5242 8118
Fax: +86 21 5236 0029
E-Mail: Daniel.chen@